Clarity Pharmaceuticals Ltd

NEW
ASX:CU6 (Australia)  
A$ 2.62 +0.13 (+5.22%) Aug 20
At Loss
P/B:
4.19
Market Cap:
A$ 977.47M ($ 698.01M)
Enterprise V:
A$ 751.22M ($ 536.45M)
Volume:
2.43M
Avg Vol (2M):
2.92M
Trade In:
Volume:
2.43M
At Loss
Avg Vol (2M):
2.92M

Clarity Pharmaceuticals Ltd (ASX:CU6) Dividend

Clarity Pharmaceuticals Ltd (ASX:CU6) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -7.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:CU6 Dividend

Does Clarity Pharmaceuticals Ltd (ASX:CU6) pay a dividend?

Clarity Pharmaceuticals Ltd (ASX:CU6) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Clarity Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Clarity Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -7.5% over the past 3 years.

What are dividend-paying alternatives to Clarity Pharmaceuticals Ltd?

For dividend-paying alternatives in Clarity Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.